Press

  • aside

    Merck Eprova and Isofol Medical Enter Exclusive Agreement for Merck Eprova’s Modufolin® in oncology

    • Leucovorin has been a mainstay of colorectal cancer treatment for 50 years • Modufolin® may offer an improved profile…

    by
  • aside

    Cancer treatment with blockbuster potential

    Investerarbolaget Yield med fokus på bolag i Göteborgsregionen har köpt in sig i medicinbolaget Isofol Medical AB. Yield har köpt…

    by